Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Strontium ranelate is no longer available for treatment.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Lokivetmab reduced itching in a dog with skin lymphoma.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Pexidartinib often causes liver issues and fatigue, especially in women.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Baricitinib may effectively treat oral lichen planus.

Letrozole reduces seizures but not brain damage in mice.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.